Am J Transplant, Volume 17, Suppl 3 Archives - Page 75 of 181 - ATC Abstracts

2017 American Transplant Congress
Impact of Cognitive Impairment on Kidney Transplantation Listing Between Sexes.
C. Haugen,¹ H. Ying,² J. Garonzik Wang,¹ M. McAdams-DeMarco,² D. Segev.^1,2
¹Surgery, JHU, Baltimore; ²Epidemiology, JHU, Baltimore
Cognitive impairment (CI) is common in end-stage renal disease (ESRD) patients and is associated with greater mortality. Despite this, cognitive function is not routinely measured…
2017 American Transplant Congress
Long-Term Consequences of Post-Donation Preeclampsia.
H. Ibrahim,¹ D. Berglund,¹ S. Jackson,² A. Matas.¹
¹UofMN, Mpls; ²M Health, Mpls
Preeclampsia (PE) has been linked to future development of ESRD in the general population. PE is more likely to occur in post-kidney donation pregnancies. Whether…
2017 American Transplant Congress
Ischemia-Reperfusion Injury-Induced Innate Immune Signaling in Human Orthotopic Liver Transplantation.
R. Sosa,¹ A. Zarrinpar,² M. Rossetti,¹ C. Lassman,¹ B. Naini,¹ N. Datta,² R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,^1,2 E. Reed.¹
¹Pathology and Laboratory Medicine, University of California, Los Angeles, CA; ²Surgery, University of California, Los Angeles, CA
Background: Ischemia-reperfusion injury (IRI) is a major risk factor in the development of acute and chronic graft rejection in orthotopic liver transplantation (OLT); however, no…
2017 American Transplant Congress
Complement Activating Anti-HLA Antibodies: Identification of Specific Histo-Mmolecular Phenotype of Rejection for Complement-Targeting Therapy.
C. Lefaucheur,¹ B. Sis,² D. Viglietti,¹ L. Hidalgo,² O. Aubert,¹ D. Glotz,¹ C. Legendre,¹ A. Zeevi,³ P. Halloran,² A. Loupy.¹
¹Paris Translational Research Center for Organ Transplantation, Paris, France; ²University of Alberta, Edmonton, Canada; ³University of Pittsburgh Medical Center, Pittsburgh
Addressing the heterogeneity of antibody-mediated allograft rejection by identifying phenotypes based on pathophysiology is critical for improving outcomes in transplantation. We investigated whether complement-binding anti-HLA…
2017 American Transplant Congress
Donor-Specific B Cell Responses: Predicting the Future of Kidney Transplants.
M. Cascalho,¹ E. Farkash,² L. Adam,¹ M. Samaniego,³ J. Platt.
¹Surgery, University of Michigan, Ann Arbor; ²Pathology, University of Michigan, Ann Arbor; ³Internal Medicine, University of Michigan, Ann Arbor
Allogeneic cell and tissue transplants nearly always evoke B cell responses ascertainable by detecting donor-specific antibodies (DSA) in the circulation of the recipient. DSA are…
2017 American Transplant Congress
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient and Allograft Survival in Long-Term Follow-Up After Kidney Transplantation.
T. Schachtner,^1,2,3 P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health BIH, Berlin, Germany
Despite rapid medical advancements in the field of transplantation, mean kidney allograft survival remained at a standstill. If and to what extent a highly specialized…
2017 American Transplant Congress
Gut Microbiota-Urinary Tract Infection Axis in Kidney Transplant Recipients.
J. Lee,¹ M. Mcgruder,¹ L. Zhang,¹ D. Dadhania,¹ M. Thangamani,¹ L. Ling,² Y. Taur,² E. Pamer,² M. Suthanthiran.¹
¹Medicine, Weill Cornell, New York, NY; ²Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Introduction. The gut microbiota has recently been identified as a risk factor for development of infectious complications like bacteremia; herein, we evaluated the relationship between…
2017 American Transplant Congress
Evolution of Lipid Profile and Major Adverse Cardiac Events in Kidney Transplant Recipients Converted from Calcineurin Inhibitor to Everolimus: 24-Month Subanalysis from Elevate Study.
M. van der Giet,¹ J. de Fijter,¹ F. Oppenheimer,¹ G. Russ,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ H. Holdaas.¹
¹ELEVATE Study Group, Berlin, Germany; ²Novartis Pharma AG, Basel, Switzerland
PURPOSE: Posttransplant (post-Tx) lipid abnormalities may increase risk of cardiovascular (CV) events in kidney transplant recipients (KTxR). Previous analysis from ELEVATE (NCT01114529) study confirmed that…
2017 American Transplant Congress
Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.
A. Khalil, S. Ganesh, C. Hughes, A. Tevar, J. Hatche, S. Esper, A. Humar.
Abdominal Transplant, UPMC, Pittsburgh, PA; Department of Surgery, Ain Shams University, Cairo, Egypt
Background: Enhanced recovery after surgery protocol has proven its efficacy in many surgery fields in controlling pain and promoting early recovery . The implication of…
2017 American Transplant Congress
Community Health, Center Proximity, and Liver Transplant Waitlist Mortality.
R. Lynch,¹ K. Ross,¹ D. Goldberg,² R. Patzer.¹
¹Surgery, Emory University, Atlanta, GA; ²Medicine, University of Pennsylvania, Philadelphia, PA
Background: While regional organ availability is frequently discussed in allocation policy, the impact of community-level factors and access to a transplant center on waitlist mortality…